ClinicalTrials.Veeva

Menu

Effects of Percutaneous Neuromodulation on Plasticity in the Somatosensory System in Healthy Subjects

C

Clinica Francisco Ortega Rehabilitacion Avanzada SL

Status

Completed

Conditions

Healthy

Treatments

Other: Ultrasound guided percutaneous neuromodulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04475133
NMP19/20-FREMPI

Details and patient eligibility

About

Echography guided percutaneous neuromodulation is a physical therapy technique, whose main objective is the treatment of pain with direct stimulation of the peripheral nerves using a rome needle of acupuncture as an active electrode for applying currents of electrostimulation.

The neurophysiological basis and the effects on the sensory and motor systems of this technique are not characterised. The present study proposes to perform the intervention on the area adjacent to the median nerve and to apply different stimulation protocols on healthy subjects to answer those questions.

Full description

Intervention is going to be performed in the medial side of the arm, where the median nerve is accessible to the intervention. The theoretical basis of the technique is to produce specific controlled changes in the somatosensory system using synaptic plasticity, to ultimate affect the perception of pain through reduction of nociception afference. Subsequently, the protocols are based on synaptic physiology and the circuitry of the somatosensory system.

The protocols are the following:

    • low-frequency and high-intensity of stimulation: 2hz during 16 min at an slightly annoying intensity, to induce synaptic depression on the c-fibers circuit, presumably carrying nociception.
    • high-frequency and low-intensity of stimulation: 100 hz in 5 second trains, separated by 1 min of no current with a perceptible but mild intensity, to induce potentiation of a-beta fibers, presumably englobing mechanoreceptors which inhibit nociception through gate control in the spinal cord.
    • placebo group has got the same intervention, but without current.

The study design is an experimental clinical trial, with randomized order of intervention with repeated measurements. This means each subject is having the three protocols at randomized order, with a gap of at least two weeks between them. The study is triple-blinded.

Somatomotor system variables, as sensory and pain pressure thresholds, grip strength, surface electromyographic activity and blood flow are evaluated on the hand of the subject. The arm to treat was also randomized for each subject The measurements are pre-intervention, post-intervention and 24 hours after the intervention for each protocol. Blood flow are measured only pre-intervention and post-intervention.

Enrollment

29 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy.
  • more than 18 years old
  • amateur athlete.

Exclusion criteria

  • to suffer or to have suffered any pathology on the arm on the last 30 days.
  • to suffer some disease discouraging current application or needle¡ing, as coagulation deficit, etc.
  • to suffer some disease as diabetes mellitus, cancer, neurology disease, depression, fibromyalgia, etc.
  • to consume drugs as coagulants, anti-depressant, pregabalin, etc during investigation or the first week before investigation.
  • to consume nsaids the last 48 hours before investigation or during investigation.
  • to consume opioids the first week before investigation or during investigation.
  • belonephobia.
  • professional athlete
  • to be pregnant
  • to suffer immunodepression

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

29 participants in 3 patient groups

Low-frequency and high-intensity
Experimental group
Description:
The intervention of ultrasound guided percutaneous neuromodulation is applied over the median nerve. The parameters are continuous stimulation of low frequency (2 hz) and high intensity (slightly painful) during 16 minutes.
Treatment:
Other: Ultrasound guided percutaneous neuromodulation
High-frequency and low-intensity
Experimental group
Description:
The intervention of ultrasound guided percutaneous neuromodulation is applied over the median nerve. The parameters are high frequency (100 hz) and low intensity trains. There are 5 trains, 5 second active current and 55 second without current per train. The current is off on the first 11 minutes and the next 5 minutes it will be on. The total time is 16 minutes.
Treatment:
Other: Ultrasound guided percutaneous neuromodulation
Control group
Sham Comparator group
Description:
The intervention of ultrasound guided percutaneous neuromodulation is applied over the median nerve without current during 16 minutes.
Treatment:
Other: Ultrasound guided percutaneous neuromodulation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems